Webinar On-Demand
Learn how Pfizer leverages the Alation Data Catalog to connect data science to the business Pfizer, one of the world’s largest pharmaceutical companies, leverages data science to do everything from improving application development to finding insights into rare diseases. To better serve the needs of the business users, Pfizer leverages an innovative analytics platform with the Alation Data Catalog. Tune in to hear Kathy Xu, Data Science Senior Associate at Pfizer, to get a view into data science at Pfizer and learn how she leverages the Alation Data Catalog to more effectively meet the needs of end-users with machine learning. In this webinar, Kathy discusses:
Pfizer’s approach to making data science work for business users
How Alation helps make data and projects easier to find and understand
Why documentation is critical to the data science teams effectiveness
Watch this educational webinar replay to learn all about data catalogs!
Webinar Registration
In this webinar, discover how to unlock the full potential of your Critical Data Elements (CDEs) by focusing on where to start, how to govern them effectively, and the value they bring when managed well. We’ll explore how Alation’s powerful features can help you define, govern, and maintain trust in CDEs to drive business outcomes while meeting regulatory demands like APRA CPS 230. Learn actionable steps to establish strong CDE governance, empowering data users to make informed decisions with trusted, compliant data.
Alation Brief
Is your organization data mature? Can people access and leverage the data they need to drive meaningful business results? Addressing this question is no easy task. Luckily, Alation has transformed thousands of hours guiding customers along this journey into an assessment you can use, too.
Webinar Registration
Gen AI capabilities are being explored across different functional areas, from Research & Development (Derisking Drug Discovery) to Clinical Trials (Accelerated time to market) to Commercials (reinventing HCP engagement). A McKinsey survey revealed that 79% of LS organizations plan to build their own gen AI solutions tailored to their unique requirements.